News

March 10, 2020

ReAlta Life Sciences Strengthens Board of Directors with Appointments of Industry Leaders Dr. Deborah Geraghty and Dr. Azmi Nabulsi

Norfolk, VA, March 10, 2020 — ReAlta Life Sciences, Inc., a biotechnology company dedicated to harnessing the power of the immune system to address life-threatening medical […]
February 6, 2020

ReAlta Life Sciences Announces FDA Orphan Drug Designation for PIC1 for the Treatment of Hypoxic-Ischemic Encephalopathy

PIC1 positioned as a novel pharmacological intervention to improve survival and cognitive outcomes for newborns affected by devastating disease Norfolk, VA, February 6, 2020 — ReAlta […]
January 2, 2020

EVMS scientist and CHKD pediatrician pursue drug for potential “blue baby” treatment

THE VIRGINIAN-PILOT | DEC 29, 2019 https://www.pilotonline.com/news/health/vp-nw-fzx19-realta-life-sciences-20191229-ufzi7vhgu5f3nppfatihjcgq3a-story.html
November 6, 2019

ReAlta Life Sciences, Inc. to participate in 3rd Annual Complement-based Drug Development Summit 2019 in Boston, Massachusetts

Norfolk, VA, November 6, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming Complement-based Drug Development Summit being held November 13-15, 2019 in Boston, […]
October 30, 2019

ReAlta Life Sciences, Inc. to participate in BIO-Europe® 2019 – 25th Annual International Partnering Conference

Norfolk, VA, October 30, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming BIOEurope® 2019 – 25th Annual International Partnering Conference being held November 11-13, […]
August 23, 2019

Ulrich Thienel MD, PhD named Chief Executive Officer of ReAlta Life Sciences, Inc.

NORFOLK, VA– Ulrich Thienel MD, PhD, has been appointed by the ReAlta Life Sciences Board of Directors as Chief Executive Officer, effective September 1, 2019.  In […]
July 2, 2019

Governor Northam Announces Commonwealth Research Commercialization Fund Award Winners

CRCF invests in priority research and commercialization activities through the private sector, academia, and nonprofit research institutes RICHMOND—Governor Ralph Northam today announced $2.51 million in funding […]
July 2, 2019

$1.5 Million Awarded to ReAlta Life Sciences by the National Institutes of Health

ReAlta Life Sciences, Inc. has been awarded a $1.5 million grant by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health […]
May 1, 2018

Three’s Company: Partnership spawns new venture that may transform care

EVMS MAGAZINE 2017-2018 | Issue 10.4  https://www.evms.edu/about_evms/administrative_offices/marketing_communications/publications/issue_10_4/
Loading...